| Madeline Corrigall, | |
|
3557 Embassy Pkwy Ste 1021, Akron, OH 44333-8358 | |
| (330) 668-4242 | |
| (330) 668-4241 |
| Full Name | Madeline Corrigall |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 3557 Embassy Pkwy Ste 1021, Akron, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235848938 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | APRN.CNP.0032629 (Ohio) | Primary |
| Entity Name | Crystal Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619906914 PECOS PAC ID: 7214821586 Enrollment ID: O20040209001226 |
News Archive
What was once speculation is now being confirmed by scientists: the brains of women and men are different in more ways than one.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
Scientists and engineers are eager to understand the secret behind bone's lightweight toughness so they can mimic it in the design of new materials, but previous studies have revealed a number of different strength mechanisms at different scales of focus, rather than a single theory.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that the European Commission has granted Orphan Medicinal Product Designation for QPI-1002 (also referred to as "I5NP") for the prophylaxis of delayed graft function in kidney transplant patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madeline Corrigall, 1315 W Market St, Akron, OH 44313-7109 Ph: (330) 221-4606 | Madeline Corrigall, 3557 Embassy Pkwy Ste 1021, Akron, OH 44333-8358 Ph: (330) 668-4242 |
News Archive
What was once speculation is now being confirmed by scientists: the brains of women and men are different in more ways than one.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
Scientists and engineers are eager to understand the secret behind bone's lightweight toughness so they can mimic it in the design of new materials, but previous studies have revealed a number of different strength mechanisms at different scales of focus, rather than a single theory.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that the European Commission has granted Orphan Medicinal Product Designation for QPI-1002 (also referred to as "I5NP") for the prophylaxis of delayed graft function in kidney transplant patients.
› Verified 5 days ago
Shakeilah Carelle Burns, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 S Arlington St Unit 146, Akron, OH 44306 Phone: 330-355-7055 | |
Felicia Zabala, APRN. CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-5995 | |
Mrs. Molly A. Hockin, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 | |
Sarah Elizabeth Bailey, CNP-APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 444 W Exchange St, Akron, OH 44302 Phone: 330-535-2671 | |
Heather Larson, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-6060 Fax: 330-543-6069 | |
Mrs. Erika Lynn Gross, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 160, Akron, OH 44302 Phone: 330-344-6505 | |
Lisa Young, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |